- Home
- SNDR vs TFX Comparison
SNDR vs TFX Comparison
Compare SNDR & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNDR | TFX |
|---|---|---|
| Founded | 1935 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.6B |
| IPO Year | 2016 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SNDR | TFX |
|---|---|---|
| Price | $26.93 | $117.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $27.77 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 901.6K | 666.4K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.48% | 1.15% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $5,674,300,000.00 | $1,992,713,000.00 |
| Revenue This Year | $5.14 | $16.02 |
| Revenue Next Year | $6.49 | $5.19 |
| P/E Ratio | $45.80 | ★ N/A |
| Revenue Growth | ★ 7.25 | N/A |
| 52 Week Low | $20.11 | $100.18 |
| 52 Week High | $30.98 | $138.93 |
Technical Indicators
Market Signals| Indicator | SNDR | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 58.85 | 60.95 |
| Support Level | $26.52 | $117.09 |
| Resistance Level | $27.46 | $123.74 |
| Average True Range (ATR) | 0.76 | 3.32 |
| MACD | 0.40 | 1.16 |
| Stochastic Oscillator | 94.33 | 84.41 |
Price Performance
Historical ComparisonAbout SNDR Schneider National Inc.
Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.